




Searching News Database: Amylin Pharmaceuticals
HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
HSMN NewsFeed - 31 Jan 2019
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
HSMN NewsFeed - 28 Feb 2018
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
HSMN NewsFeed - 23 Mar 2016
Mirati Therapeutics Announces Promotion Of Jamie A. Donadio To Chief Financial Officer
Mirati Therapeutics Announces Promotion Of Jamie A. Donadio To Chief Financial Officer
HSMN NewsFeed - 8 Jun 2015
Conatus Pharmaceuticals Appoints Jean L. Chan as Vice President, Clinical Development
Conatus Pharmaceuticals Appoints Jean L. Chan as Vice President, Clinical Development
HSMN NewsFeed - 28 May 2015
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
HSMN NewsFeed - 30 Aug 2013
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
HSMN NewsFeed - 19 Mar 2013
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
HSMN NewsFeed - 19 Feb 2013
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 10 Jul 2012
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
HSMN NewsFeed - 4 Jan 2012
Digirad Names Sarah L. Hanssen Senior Vice President of Strategic Marketing and Business Development
Digirad Names Sarah L. Hanssen Senior Vice President of Strategic Marketing and Business Development
HSMN NewsFeed - 1 Jun 2010
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
HSMN NewsFeed - 9 Sep 2008
Metabasis Therapeutics Appoints Dr. Molly Holman as Vice President of Intellectual Property
Metabasis Therapeutics Appoints Dr. Molly Holman as Vice President of Intellectual Property
HSMN NewsFeed - 18 Aug 2008
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
HSMN NewsFeed - 1 Oct 2007
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
HSMN NewsFeed - 23 Jun 2007
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
HSMN NewsFeed - 30 Jan 2007
PsychoGenics Announces the Launch of Psylin Neurosciences, Inc. in Partnership with Amylin Pharmaceuticals
PsychoGenics Announces the Launch of Psylin Neurosciences, Inc. in Partnership with Amylin Pharmaceuticals
HSMN NewsFeed - 22 Dec 2006
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
HSMN NewsFeed - 21 Nov 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
HSMN NewsFeed - 12 Jun 2006
Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
HSMN NewsFeed - 1 Mar 2006
Supplemental New Drug Application for BYETTA Submitted to FDA for Use With TZDs
Supplemental New Drug Application for BYETTA Submitted to FDA for Use With TZDs
HSMN NewsFeed - 21 Feb 2006
Vasogen Announces Plans for Terrance H. Gregg to Succeed William R. Grant as Chairman
Vasogen Announces Plans for Terrance H. Gregg to Succeed William R. Grant as Chairman
Additional items found! 32

Members Archive contains
32 additional stories matching:
Amylin Pharmaceuticals
(Password required)
Amylin Pharmaceuticals
(Password required)